• A Massachusetts ballot question that would allow adults to grow, use, and possess many psychedelic substances appears poised for defeat.
• With 80% of precincts reporting, opponents of the measure are leading 56.7% to 43.3%.
• The substances that would be legalized under the proposal are psilocybin and psilocin, which are found in "magic mushrooms," as well as dimethyltryptamine, mescaline, and ibogaine.
• Oregon and Colorado already allow the use of some psychedelic substances.
• Psychedelic drug developers: Mind Medicine (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS), Cybin (NYSE:CYBN), Atai Life Sciences (NASDAQ:ATAI), Enveric Bio (ENVB), Revive Therapeutics (OTCQB:RVVTF), Bright Minds Biosciences (DRUG), GH Research (GHRS), Clearmind Medicine (CMND).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.